About Coag-Sense
Coag-Sense is a Healthcare company based in San Francisco (United States) founded in 2008 by Duane Yamasaki. It operates as a portable PTINR monitors are manufactured using micromechanical clot detection. Coag-Sense has raised $10 million across 2 funding rounds. Its chief executive is Doug Patterson. Coag-Sense offers products and services including PT/INR Monitoring System, PT2, and Accessories. Its focus areas include Life Sciences, Hematology, Medical Devices and Monitoring. Its legal entity is CoaguSense, Inc. Its competitors include Accriva Diagnostics, Diagnostica Stago, Entegrion, Enzyre and MedicQuant ApS and 4 more; 6 of its 9 listed competitors have raised funding.
Company details
Coag-Sense was founded in 2008 in San Francisco, United States, focusing on medical devices for coagulation monitoring. The PTINR system is produced with direct micromechanical technology that mimics the WHO tilt-tube method, requiring only 10 microliters of fingerstick blood. Plasma controls can be tested without complications, and results are unaffected by low hemoglobin or hematocrit levels. Operations center on point-of-care diagnostics for anticoagulant therapy management.
- Headquarters San Francisco, United States
- Founders Duane Yamasaki
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website coag-sense.com
- Social LinkedIn YouTube
- Legal Name Coagusense, Inc.
- Total Equity Funding$10M (USD)
in 2 rounds
- Latest Funding Round$5M (USD), Series A
Nov 2016
Products & Services of Coag-Sense
Coag-Sense offers a comprehensive portfolio of products and services, including PT/INR Monitoring System, PT2, and Accessories.
Provides accurate prothrombin time testing for anticoagulation therapy.
Portable device for direct clot detection in blood testing.
Includes strips and tools for PT/INR system operation.
Apps and channels of Coag-Sense
its YouTube channel Coag-Sense PT/INR Monitoring System has 928 subscribers and 18 videos.
Videos from Coag-Sense
The most watched videos on Coag-Sense's YouTube channel, Coag-Sense PT/INR Monitoring System (928 subscribers). Click a video to play it here.
More on Coag-Sense PT/INR Monitoring System.
Funding Insights of Coag-Sense
Coag-Sense has successfully raised a total of $10M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in November 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10M
- Total Rounds 2
- Last Round Series A — $5M
- First Round $5M
(Nov 2016)
All 2 funding rounds of Coag-Sense with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2016 | $5M | Series A | – | – | – |
| Nov 2016 | $5M | Series A | – | – | – |
People of Coag-Sense
2 people are tracked at Coag-Sense (2 in leadership).
| Name | Role | Group |
|---|---|---|
Duane Yamasaki | Co-Founder | Leadership |
Doug Patterson | CEO & President | Leadership |
Complete people profiles for Coag-Sense
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Coag-Sense
3 dated milestones of Coag-Sense across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Coag-Sense is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series A, of $5.0M.
Competitors of Coag-Sense
Coag-Sense has 9 listed competitors in our database, 6 of them funded. They include Accriva Diagnostics, Diagnostica Stago, Entegrion, Enzyre and MedicQuant ApS, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| accriva.com | 2009 | San Diego, United States | $216.01M | 399 | Near-patient diagnostic systems for coagulation testing are developed. | |
| stago.com | 1998 | Paris, France | – | – | A portfolio of hemostasis and coagulation diagnostic products is manufactured. | |
| entegrion.com | 2002 | Durham, United States | $30.45M | 4 | Hemostasis and fluid replacement products are provided for medical applications. | |
| enzyre.com | 2016 | Nijmegen, Netherlands | $11.88M | – | Smart diagnostics devices for blood coagulation analysis are developed. | |
| medicquant.com | 2019 | Aarhus, Denmark | – | 7 | Diagnostic kits for blood anticoagulant detection are provided. | |
| perosphere.com | 2011 | Mount Kisco, United States | $9.36M | 13 | Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury. | |
| medicalingenuities.com | 2011 | Wheaton, United States | $997,133 | – | Developer of radial artery occlusion devices for hematology treatments | |
| microvisk.com | 2004 | Saint Asaph, United Kingdom | $16.62M | – | Handheld devices for blood clot monitoring are provided by Microvisk. | |
| tarabios.com | 2019 | Sarıyer, Turkey | – | – | A self-diagnostic device for blood coagulation time is developed. |
Detailed competitors of Coag-Sense
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Coag-Sense
The website of Coag-Sense (coag-sense.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▼ 6.9% vs previous month
Top companies in Hematology
10 companies that operate in the same segment as Coag-Sense (Hematology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small activating RNA therapeutics are developed to restore gene function. | 2008 | London, England, United Kingdom | USD 460.41 M | USD 23.07 M | 37 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | – | 384 | |
Developer of therapeutics for the treatment of hematologic diseases | 2017 | Cambridge, Massachusetts, United States | USD 140 M | – | 84 | |
Gene therapy platform is developed for chronic disease treatments. | 2015 | Stevenage, Hertfordshire, United Kingdom | USD 273.69 M | USD 435.87 K | 152 | |
Novel anticoagulants for thrombosis treatment are developed. | 2019 | Cambridge, Massachusetts, United States | USD 250 M | – | 13 | |
Developer of therapies for treating hemochromatosis & beta thalassemia | 1989 | San Diego, California, United States | – | USD 75.72 M | 71 | |
Breakthrough therapies are developed for blood diseases and infections. | 2014 | Buffalo, New York, United States | USD 1 M | – | 22 | |
Hematology products and solutions are provided for medical applications. | 1971 | Braintree, Massachusetts, United States | – | USD 1.33 B | 3,020 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Coag-Sense
Complete news archive for Coag-Sense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Coag-Sense
Coag-Sense was founded in 2008 and raised its 1st funding round 8 years after it was founded.
Coag-Sense is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Doug Patterson is the current CEO of Coag-Sense.
Coag-Sense is a funded company, having raised a total of $10M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Nov 2016.
Coag-Sense was founded in 2008 in San Francisco, United States, focusing on medical devices for coagulation monitoring. The PTINR system is produced with direct micromechanical technology that mimics the WHO tilt-tube method, requiring only 10 microliters of fingerstick blood. Plasma controls can be tested without complications, and results are unaffected by low hemoglobin or hematocrit levels. Operations center on point-of-care diagnostics for anticoagulant therapy management.
Coag-Sense's top competitors include Accriva Diagnostics, Diagnostica Stago and MedicQuant ApS.
Coag-Sense offers PT/INR Monitoring System, PT2, and Accessories.
Coag-Sense operates through Coagusense, Inc..